A world without Alzheimer’s

The first practice guidelines for the clinical evaluation of cognitive impairment due to Alzheimer’s disease and related dementias (ADRD) were released earlier this year by the American Alzheimer’s Association workgroup.

Read More
CPD POINTS: 0

Inhalant allergens predicting allergy to animals

Sensitisation to furry animals seems to be on the increase globally and it appears that sensitisation in early childhood can precede respiratory allergy in adolescence.

Read More
CPD POINTS: 0

7 key recommendations for management after PFO closure

The first position paper on the management of patients with patent foramen ovale (PFO) and left circulation embolism explores the available trial evidence and define the principles needed to guide decision-making.

Read More
CPD POINTS: 0

Avoid laundry list in GORD management

Although gastro-oesophageal reflux disease (GORD) is not age specific, people older than 40 are most affected.

Read More
CPD POINTS: 0

The stepped care model

The new National Institute of Health Care Excellence guideline proposes a stepped care model for the management of patients with chronic depression.

Read More
CPD POINTS: 0

Multiple sclerosis 101

Multiple sclerosis (MS) affects an estimated 30 people per 100 000 population. In South Africa this number is slightly higher at 32 people per 100 000 population.

Read More
CPD POINTS: 0

Patient autonomy: Informed consent

Below are sections 6 to 9 of the National Health Act, which deal directly with then concepts of patient autonomy and informed consent.

Read More
CPD POINTS: 0

New hope for men with mCRPC

Androgen deprivation therapy has been the mainstay of treatment for advanced and metastatic prostate cancer, but the treatment is not curative and most men progress to mCRPC.

Read More
CPD POINTS: 0

As time goes by

The treatment of hypertension using drugs and the achieved benefits of such treatment is founded on a solid body of evidence representing a very large number of well-conducted randomised clinical trials.

Read More
CPD POINTS: 0

SAOJ Spring 2018 CPDs

See below for the quiz you need to answer to obtain CPD points for the Spring 2018 issue of the SA Ophthalmology Journal.

Read More
CPD POINTS: 3

Long-term PPI use: are concerns justified?

Recent studies have raised concerns about the possible adverse effects of long-term proton pump inhibitor (PPI) use, but are these really clinically significant?

Read More
CPD POINTS: 1

Biofilms and antibiotic resistance

The rise of multidrug resistant bacteria caused by growing antibiotic resistance is one of the gravest threats faced by modern medicine. Could biofilms be a part of the solution?

Read More
CPD POINTS: 0

Closing the care-gap for fracture patients

Specialist Forum December 2018 CPD 1 of 3: Prominent spinal surgeon Dr Reggie King about the role of orthopaedic surgeons in the treatment of patients with a fragility fracture in the emergency department.

Read More
CPD POINTS: 0

NICE bipolar guideline

Specialist Forum December 2018 CPD 2 of 3: NICE has warned against the use of valproate during pregnancy in its updated guideline on the management of bipolar disorder.

Read More
CPD POINTS: 0

Hodgkin lymphoma guideline 2018

Specialist Forum December 2018 CPD 3 of 3: With modern treatment strategies, 80%–90% of patients with Hodgkin lymphoma achieve permanent remission, according to the European Society for Medical Oncology’s new HL guideline.

Read More
CPD POINTS: 0

Specialist Forum December CPDs

These are the Specialist Forum’s December CPDs. Click on the questionnaire below to start the CPD quiz.

Read More
CPD POINTS: 3

Synthetic folic acid, food folate and 5-MTHF are not the same thing

MEDICAL CHRONICLE DECEMBER 2018 CPD 1 of 3: The terms folic acid, folacin, folinic acid, pteroylglutamic acid and folate seem to be used interchangeably. However, they are not the same thing.

Read More
CPD POINTS: 0

CoQ10 in diabetes and high cholesterol patients

MEDICAL CHRONICLE DECEMBER 2018 CPD 2 of 3: The demand for CoQ10 as a dietary supplement has dramatically increased in recent years due to its reported beneficial effects in cardiovascular diseases and other conditions.

Read More
CPD POINTS: 0

Dapagliflozin DECLARE: Latest SGLT2 CV outcomes trial

MEDICAL CHRONICLE DECEMBER 2018 CPD 3 of 3: Recently the DECLARE trial was published evaluating in a randomised, double-blind, multinational, placebo- controlled trial, the effect of Dapagliflozin on safety and efficacy for macrovascular and microvascular outcomes.

Read More
CPD POINTS: 0

Medical Chronicle December CPDs

These are Medical Chronicle’s December CPDs. Click on the attached questionnaire to start the CPD quiz.

Read More
CPD POINTS: 3
« » page 1 / 14